Atomistry » Fluorine » PDB 4e3n-4f9m » 4e4x
Atomistry »
  Fluorine »
    PDB 4e3n-4f9m »
      4e4x »

Fluorine in PDB 4e4x: Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor

Enzymatic activity of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor

All present enzymatic activity of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor, PDB code: 4e4x was solved by W.C.Voegtli, H.L.Sturgis, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.86 / 3.60
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 109.000, 109.000, 155.210, 90.00, 90.00, 90.00
R / Rfree (%) 29.9 / 33.8

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor (pdb code 4e4x). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor, PDB code: 4e4x:
Jump to Fluorine binding site number: 1; 2; 3; 4;

Fluorine binding site 1 out of 4 in 4e4x

Go back to Fluorine Binding Sites List in 4e4x
Fluorine binding site 1 out of 4 in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F801

b:53.7
occ:1.00
F19 A:T1Q801 0.0 53.7 1.0
C18 A:T1Q801 1.4 50.6 1.0
C13 A:T1Q801 2.4 51.0 1.0
C17 A:T1Q801 2.4 49.4 1.0
C9 A:T1Q801 2.8 51.4 1.0
C10 A:T1Q801 3.3 51.1 1.0
CB A:ALA481 3.4 45.3 1.0
OG1 A:THR529 3.6 36.7 1.0
C14 A:T1Q801 3.7 50.5 1.0
C16 A:T1Q801 3.7 48.8 1.0
C8 A:T1Q801 3.7 52.0 1.0
C A:ALA481 3.7 46.4 1.0
N A:LYS483 3.7 56.6 1.0
O A:ALA481 3.7 44.7 1.0
CB A:LYS483 3.8 62.1 1.0
N A:VAL482 3.9 49.0 1.0
C A:VAL482 4.0 53.5 1.0
CG1 A:VAL471 4.0 56.0 1.0
O12 A:T1Q801 4.0 51.9 1.0
C15 A:T1Q801 4.2 49.5 1.0
CA A:ALA481 4.2 45.3 1.0
CA A:VAL482 4.3 51.6 1.0
CA A:LYS483 4.3 61.1 1.0
CG2 A:THR529 4.3 38.5 1.0
C5 A:T1Q801 4.4 52.2 1.0
O A:VAL482 4.5 53.2 1.0
O A:ILE527 4.5 45.1 1.0
CB A:THR529 4.5 37.6 1.0
N7 A:T1Q801 4.6 52.4 1.0
N A:THR529 4.6 38.6 1.0
F20 A:T1Q801 4.8 53.3 1.0
CD A:LYS483 4.8 65.3 1.0
CG2 A:VAL471 4.9 57.3 1.0
CG A:LYS483 4.9 64.3 1.0
C4 A:T1Q801 5.0 52.9 1.0

Fluorine binding site 2 out of 4 in 4e4x

Go back to Fluorine Binding Sites List in 4e4x
Fluorine binding site 2 out of 4 in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F801

b:53.3
occ:1.00
F20 A:T1Q801 0.0 53.3 1.0
C14 A:T1Q801 1.4 50.5 1.0
C13 A:T1Q801 2.4 51.0 1.0
C15 A:T1Q801 2.4 49.5 1.0
N21 A:T1Q801 2.8 49.8 1.0
C9 A:T1Q801 2.8 51.4 1.0
C8 A:T1Q801 3.3 52.0 1.0
O12 A:T1Q801 3.3 51.9 1.0
CD2 A:LEU514 3.3 35.1 1.0
N A:ASP594 3.4 45.7 1.0
C10 A:T1Q801 3.7 51.1 1.0
C18 A:T1Q801 3.7 50.6 1.0
C16 A:T1Q801 3.7 48.8 1.0
CA A:GLY593 3.9 41.5 1.0
CE1 A:PHE583 3.9 34.4 1.0
C A:GLY593 4.0 44.8 1.0
CA A:ASP594 4.1 46.8 1.0
C17 A:T1Q801 4.2 49.4 1.0
CZ A:PHE583 4.2 34.0 1.0
CB A:ASP594 4.3 47.5 1.0
N7 A:T1Q801 4.3 52.4 1.0
S23 A:T1Q801 4.4 50.2 1.0
C5 A:T1Q801 4.7 52.2 1.0
F19 A:T1Q801 4.8 53.7 1.0
CG A:LEU514 4.8 34.7 1.0
O A:GLY593 4.9 47.3 1.0
C4 A:T1Q801 5.0 52.9 1.0

Fluorine binding site 3 out of 4 in 4e4x

Go back to Fluorine Binding Sites List in 4e4x
Fluorine binding site 3 out of 4 in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F801

b:48.9
occ:1.00
F19 B:T1Q801 0.0 48.9 1.0
C18 B:T1Q801 1.4 46.5 1.0
C13 B:T1Q801 2.4 46.4 1.0
C17 B:T1Q801 2.4 46.0 1.0
C9 B:T1Q801 2.8 45.8 1.0
CB B:ALA481 3.3 45.0 1.0
C10 B:T1Q801 3.4 46.5 1.0
C8 B:T1Q801 3.5 45.2 1.0
C B:ALA481 3.7 45.9 1.0
C14 B:T1Q801 3.7 45.8 1.0
C16 B:T1Q801 3.7 45.6 1.0
CG1 B:VAL471 3.7 54.1 1.0
OG1 B:THR529 3.7 36.9 1.0
N B:LYS483 3.7 56.8 1.0
O B:ALA481 3.8 45.7 1.0
CB B:LYS483 3.8 61.5 1.0
O12 B:T1Q801 3.8 43.2 1.0
N B:VAL482 3.9 47.1 1.0
C B:VAL482 3.9 53.2 1.0
CA B:ALA481 4.1 45.0 1.0
C15 B:T1Q801 4.2 44.9 1.0
CA B:VAL482 4.2 50.2 1.0
CA B:LYS483 4.2 60.5 1.0
O B:VAL482 4.3 53.8 1.0
C5 B:T1Q801 4.5 46.2 1.0
N7 B:T1Q801 4.5 46.5 1.0
CG2 B:THR529 4.6 38.1 1.0
O B:ILE527 4.6 43.6 1.0
CG2 B:VAL471 4.7 54.8 1.0
CB B:THR529 4.7 37.1 1.0
CB B:VAL471 4.8 54.7 1.0
F20 B:T1Q801 4.8 47.8 1.0
CD B:LYS483 4.8 66.1 1.0
N B:THR529 4.8 36.5 1.0
CG B:LYS483 4.9 64.5 1.0
C4 B:T1Q801 5.0 46.5 1.0

Fluorine binding site 4 out of 4 in 4e4x

Go back to Fluorine Binding Sites List in 4e4x
Fluorine binding site 4 out of 4 in the Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Crystal Structure of B-Raf Kinase Domain in Complex with A Dihydropyrido[2,3-D]Pyrimidinone-Based Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F801

b:47.8
occ:1.00
F20 B:T1Q801 0.0 47.8 1.0
C14 B:T1Q801 1.4 45.8 1.0
C13 B:T1Q801 2.4 46.4 1.0
C15 B:T1Q801 2.4 44.9 1.0
N21 B:T1Q801 2.8 42.8 1.0
C9 B:T1Q801 2.8 45.8 1.0
CD2 B:LEU514 3.1 34.5 1.0
C8 B:T1Q801 3.4 45.2 1.0
O12 B:T1Q801 3.5 43.2 1.0
C10 B:T1Q801 3.5 46.5 1.0
CE1 B:PHE583 3.7 31.5 1.0
C18 B:T1Q801 3.7 46.5 1.0
C16 B:T1Q801 3.7 45.6 1.0
N B:ASP594 3.7 44.0 1.0
CA B:GLY593 4.0 39.5 1.0
CZ B:PHE583 4.0 30.3 1.0
C B:GLY593 4.1 41.9 1.0
C17 B:T1Q801 4.2 46.0 1.0
CA B:ASP594 4.4 46.6 1.0
N7 B:T1Q801 4.4 46.5 1.0
S23 B:T1Q801 4.4 40.4 1.0
C27 B:T1Q801 4.5 34.1 1.0
CB B:ASP594 4.5 47.1 1.0
CG B:LEU514 4.6 35.8 1.0
C5 B:T1Q801 4.6 46.2 1.0
F19 B:T1Q801 4.8 48.9 1.0
CD1 B:PHE583 4.9 32.8 1.0
C4 B:T1Q801 4.9 46.5 1.0

Reference:

L.Ren, K.A.Ahrendt, J.Grina, E.R.Laird, A.J.Buckmelter, J.D.Hansen, B.Newhouse, D.Moreno, S.Wenglowsky, V.Dinkel, S.L.Gloor, G.Hastings, S.Rana, K.Rasor, T.Risom, H.L.Sturgis, W.C.Voegtli, S.Mathieu. The Discovery of Potent and Selective Pyridopyrimidin-7-One Based Inhibitors of B-Raf(V600E) Kinase. Bioorg.Med.Chem.Lett. V. 22 3387 2012.
ISSN: ISSN 0960-894X
PubMed: 22534450
DOI: 10.1016/J.BMCL.2012.04.015
Page generated: Sun Dec 13 12:01:52 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy